519 related articles for article (PubMed ID: 31443650)
21. Increased Serum Interleukin-10 but not Interleukin-4 Level in Children with Mycoplasma pneumoniae Pneumonia.
Medjo B; Atanaskovic-Markovic M; Nikolic D; Radic S; Lazarevic I; Cirkovic I; Djukic S
J Trop Pediatr; 2017 Aug; 63(4):294-300. PubMed ID: 28057814
[TBL] [Abstract][Full Text] [Related]
22. β2 microglobulin and lactate dehydrogenase are indices of different features of Mycoplasma pneumoniae-associated community-acquired lower respiratory tract infection for severity evaluation in children.
Kusubae R; Nomura Y; Hirabayashi M; Sameshima K
J Infect Chemother; 2019 Dec; 25(12):1007-1011. PubMed ID: 31227380
[TBL] [Abstract][Full Text] [Related]
23. Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia.
Tang M; Wang D; Tong X; Wu Y; Zhang J; Zhang L; Yin Y; Cao Q
BMC Pediatr; 2021 Feb; 21(1):90. PubMed ID: 33607971
[TBL] [Abstract][Full Text] [Related]
24. Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia.
Marc E; Chaussain M; Moulin F; Iniguez JL; Kalifa G; Raymond J; Gendrel D
Pediatr Infect Dis J; 2000 Aug; 19(8):706-10. PubMed ID: 10959737
[TBL] [Abstract][Full Text] [Related]
25. [Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015].
Aguilera-Alonso D; López Ruiz R; Centeno Rubiano J; Morell García M; Valero García I; Ocete Mochón MD; Montesinos Sanchis E
An Pediatr (Engl Ed); 2019 Jul; 91(1):21-29. PubMed ID: 30679135
[TBL] [Abstract][Full Text] [Related]
26. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia.
Zhan XW; Deng LP; Wang ZY; Zhang J; Wang MZ; Li SJ
Ital J Pediatr; 2022 Nov; 48(1):190. PubMed ID: 36435821
[TBL] [Abstract][Full Text] [Related]
27. Application value of antibody titres and RNA detection in the early prediction of Mycoplasma pneumoniae pneumonia in children: a retrospective study.
Tuo W; Guo X; Wu M; Xie S; Shen X; Wang J; Cai Q; Yuan C; Yao C; Xiang Y
BMC Infect Dis; 2023 Apr; 23(1):220. PubMed ID: 37029345
[TBL] [Abstract][Full Text] [Related]
28. Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children.
Liu TY; Lee WJ; Tsai CM; Kuo KC; Lee CH; Hsieh KS; Chang CH; Su YT; Niu CK; Yu HR
Pediatr Neonatol; 2018 Oct; 59(5):501-506. PubMed ID: 29337082
[TBL] [Abstract][Full Text] [Related]
29. Mutations in domain V of
Xu C; Deng H; Zhang J; Zhu Y; Rong Q; Quan Y; Tang H; Zhao D
J Int Med Res; 2021 Jun; 49(6):3000605211016376. PubMed ID: 34082582
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive
Ha SG; Oh KJ; Ko KP; Sun YH; Ryoo E; Tchah H; Jeon IS; Kim HJ; Ahn JM; Cho HK
J Korean Med Sci; 2018 Oct; 33(43):e268. PubMed ID: 30344461
[TBL] [Abstract][Full Text] [Related]
31. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
[TBL] [Abstract][Full Text] [Related]
32. [Mixed infections in children with Mycoplasma pneumoniae pneumonia].
Chen LL; Cheng YG; Chen ZM; Li SX; Li XJ; Wang YS
Zhonghua Er Ke Za Zhi; 2012 Mar; 50(3):211-5. PubMed ID: 22801206
[TBL] [Abstract][Full Text] [Related]
33. Clinical Usefulness of Serum Lactate Dehydrogenase Levels in Mycoplasma pneumoniae Pneumonia in Children.
Lee E; Choi I
Indian J Pediatr; 2022 Oct; 89(10):1003-1009. PubMed ID: 35665905
[TBL] [Abstract][Full Text] [Related]
34. Imbalance of peripheral blood Th17 and Treg responses in children with refractory Mycoplasma pneumoniae pneumonia.
Guo H; He Z; Li M; Wang T; Zhang L
J Infect Chemother; 2016 Mar; 22(3):162-6. PubMed ID: 26806148
[TBL] [Abstract][Full Text] [Related]
35. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.
Li P; Wang W; Zhang X; Pan J; Gong L
Sci Rep; 2024 Mar; 14(1):5632. PubMed ID: 38453960
[TBL] [Abstract][Full Text] [Related]
36. [Comparative analysis of clinical characteristics and prognosis between bacterial necrotizing pneumonia and
Zhang YY; Dai LM; Zhou YL; Yang DH; Tang LF; Chen ZM
Zhonghua Er Ke Za Zhi; 2019 Aug; 57(8):625-630. PubMed ID: 31352749
[No Abstract] [Full Text] [Related]
37. Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia.
Zhang J; Wang T; Li R; Ji W; Yan Y; Sun Z; Tan J; Wu J; Huang L; Chen Z
BMC Infect Dis; 2021 Jan; 21(1):67. PubMed ID: 33441105
[TBL] [Abstract][Full Text] [Related]
38. Utility of Assessing Cytokine Levels for the Differential Diagnosis of Pneumonia in a Pediatric Population.
Zhou JM; Ye Q
Pediatr Crit Care Med; 2017 Apr; 18(4):e162-e166. PubMed ID: 28198756
[TBL] [Abstract][Full Text] [Related]
39. A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia.
Wang L; Feng Z; Zhao M; Yang S; Yan X; Guo W; Shi Z; Li G
BMC Infect Dis; 2017 Jul; 17(1):518. PubMed ID: 28743259
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of Q-Probe PCR in Detecting Macrolide-Resistant Mycoplasma pneumoniae Infection in Children.
Muto T; Nakamura N; Masuda Y; Numoto S; Kodama S; Miyamoto R; Hayakawa T; Mori H; Iwayama H; Kurahashi H; Agata H; Okumura A
Jpn J Infect Dis; 2022 Jan; 75(1):89-91. PubMed ID: 34193662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
